| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |